Carlsmed (CARL) Total Non-Current Liabilities (2024 - 2026)

Carlsmed (CARL) has reported Total Non-Current Liabilities for 3 consecutive years, with $33.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Non-Current Liabilities rose 25.01% year-over-year to $33.6 million; the trailing twelve-month figure through Jun 2026 stood at $33.6 million (up 25.01% YoY), and the FY2025 full-year result was $30.9 million, up 20.07% from the prior year.
• Total Non-Current Liabilities climbed to $33.6 million in Q2 2026 per CARL's latest filing, from $26.2 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $33.6 million in Q2 2026 and bottomed at $25.8 million in Q4 2024.
• Historically, Total Non-Current Liabilities has averaged $28.6 million across 3 years, with a median of $27.4 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities gained 20.07% in 2025, then grew 25.01% in 2026.
• Over 3 years, Total Non-Current Liabilities stood at $25.8 million in 2024, then grew by 20.07% to $30.9 million in 2025, then climbed by 8.63% to $33.6 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $33.6 million, $26.2 million, and $30.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.